The Closing Is Not the End—It Is the Beginning: For many physician owners, the closing of the transaction represents the culmination of a multi-year planning and preparation process. But for the PE sponsor acquiring the practice, closing day is day one of a 5- to 7-year value-creation effort. Understanding what the post-closing period entails and what physicians should expect regarding their professional life, compensation, autonomy, and relationship with the new ownership is essential context for evaluating any transaction opportunity before it is consummated.
The First 100 Days: Integration Priorities
The initial 100 days following a PE acquisition are typically the most intensive from an operational standpoint. PE sponsors generally move quickly to implement shared administrative infrastructure, integrate the practice’s financial reporting into the platform’s management systems, and identify early synergy opportunities. For physicians, this period often involves a transition from the familiar rhythms of independent practice management to operating within a more structured corporate governance environment, with monthly financial reporting, KPI tracking, and regular interaction with PE firm operating partners and portfolio management teams.
Employment Agreements and Compensation Transition
Almost universally, physicians who sell their practices to PE-backed platforms enter into formal employment agreements at closing. These agreements typically run 3 to 5 years and include a base salary, productivity incentives tied to wRVUs or collections, participation in practice-wide profit sharing, and post-closing restrictive covenants (non-competes, non-solicitation). The transition from practice owner to employed physician, even a highly compensated employed physician with significant rollover equity, represents a meaningful shift in professional identity and daily operational reality. Physicians who understand and anticipate this transition are better positioned to navigate it successfully.
Clinical Autonomy: What to Expect
One of the most common concerns among physicians considering a PE transaction is the potential impact on clinical autonomy. The degree to which clinical autonomy is preserved post-transaction varies significantly across PE sponsors and platform operators. The strongest platforms have recognized that physician satisfaction and clinical culture are directly linked to patient retention, physician recruitment, and practice EBITDA, all of which PE sponsors care deeply about. The practices that have successfully negotiated and documented specific clinical governance provisions in their employment and transaction agreements, including rights regarding hiring, clinical protocols, and patient care standards, have generally fared better on the autonomy dimension than those that relied on informal assurances.
The Exit and the Second Bite
For physicians who retained rollover equity at closing, the PE sponsor’s eventual exit is the next major financial event of the transaction cycle. PE holding periods have been extending in recent years, with many healthcare platforms now anticipating 5 to 7 year holds before a secondary sale or other exit. When the exit occurs, physicians holding rollover equity will receive their proportional share of exit proceeds, potentially generating significant returns if the platform has grown successfully. Physicians considering a transaction should model the expected rollover equity return over realistic holding periods and under multiple assumptions as part of their overall transaction evaluation.